SURMOUNT-5: Tirzepatide and semaglutide go head-to-head in battle of weight loss drugs
Eli Lilly and Company has registered its intent to carry out a Phase 3b clinical trial that will see the company’s tirzepatide (Mounjaro)...
top of page
Browse by category
Search
Browse by tag
bottom of page